Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects

被引:83
|
作者
Di Domenico, Fabio [1 ,2 ]
Sultana, Rukhsana [1 ]
Barone, Eugenio [1 ,3 ]
Perluigi, Marzia [2 ]
Cini, Chiara [2 ,4 ]
Mancuso, Cesare [3 ]
Cai, Jian [5 ]
Pierce, William M. [5 ]
Butterfield, D. Allan [1 ]
机构
[1] Univ Kentucky, Dept Chem, Ctr Membrane Sci, Sanders Brown Ctr Aging, Lexington, KY 40506 USA
[2] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy
[3] Catholic Univ, Sch Med, Inst Pharmacol, I-00168 Rome, Italy
[4] CNR, Inst Mol Biol & Pathol, I-00185 Rome, Italy
[5] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA
关键词
Alzheimer's disease; Protein phosphorylation; Phosphoproteomics; 2-DE; MILD COGNITIVE IMPAIRMENT; FIBRILLARY ACIDIC PROTEIN; PAIRED HELICAL FILAMENTS; OXIDATIVELY MODIFIED PROTEINS; INFERIOR PARIETAL LOBULE; CREATINE-KINASE BB; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PHOSPHOPROTEOMIC ANALYSIS; TRANSGENIC MICE; 6-PHOSPHOGLUCONATE DEHYDROGENASE;
D O I
10.1016/j.jprot.2011.03.033
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Phosphorylation on tyrosine, threonine and serine residues represents one of the most important post-translational modifications and is a key regulator of cellular signaling of multiple biological processes that require a strict control by protein kinases and protein phosphatases. Abnormal protein phosphorylation has been associated with several human diseases including Alzheimer's disease (AD). One of the characteristic hallmarks of AD is the presence of neurofibrillary tangles, composed of microtubule-associated, abnormally hyperphosphorylated tau protein. However, several others proteins showed altered phosphorylation levels in AD suggesting that deregulated phosphorylation may contribute to AD pathogenesis. Phosphoproteomics has recently gained attention as a valuable approach to analyze protein phosphorylation, both in a quantitative and a qualitative way. We used the fluorescent phosphospecific Pro-Q Diamond dye to identify proteins that showed alterations in their overall phosphorylation in the hippocampus of AD vs. control (CTR) subjects. Significant changes were found for 17 proteins involved in crucial neuronal process such as energy metabolism or signal transduction. These phosphoproteome data may provide new clues to better understand molecular pathways that are deregulated in the pathogenesis and progression of AD. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:1091 / 1103
页数:13
相关论文
共 50 条
  • [21] Translational proteomics in Alzheimer's disease and related disorders
    Ghidoni, Roberta
    Paterlini, Anna
    Benussi, Luisa
    CLINICAL BIOCHEMISTRY, 2013, 46 (06) : 480 - 486
  • [22] Plasma protein profiling of Mild Cognitive Impairment and Alzheimer’s disease using iTRAQ quantitative proteomics
    Fei Song
    Anne Poljak
    Nicole A Kochan
    Mark Raftery
    Henry Brodaty
    George A Smythe
    Perminder S Sachdev
    Proteome Science, 12
  • [23] Plasma protein profiling of Mild Cognitive Impairment and Alzheimer's disease using iTRAQ quantitative proteomics
    Song, Fei
    Poljak, Anne
    Kochan, Nicole A.
    Raftery, Mark
    Brodaty, Henry
    Smythe, George A.
    Sachdev, Perminder S.
    PROTEOME SCIENCE, 2014, 12
  • [24] Quantitative evaluation of Alzheimer's disease
    Caroli, Anna
    Frisoni, Giovanni B.
    EXPERT REVIEW OF MEDICAL DEVICES, 2009, 6 (05) : 569 - 588
  • [25] Proteomics analysis of prefrontal cortex of Alzheimer’s disease patients revealed dysregulated proteins in the disease and novel proteins associated with amyloid-β pathology
    Ana Montero-Calle
    Raquel Coronel
    María Garranzo-Asensio
    Guillermo Solís-Fernández
    Alberto Rábano
    Vivian de los Ríos
    María Jesús Fernández-Aceñero
    Marta L. Mendes
    Javier Martínez-Useros
    Diego Megías
    María Teresa Moreno-Casbas
    Alberto Peláez-García
    Isabel Liste
    Rodrigo Barderas
    Cellular and Molecular Life Sciences, 2023, 80
  • [26] Proteomics analysis of prefrontal cortex of Alzheimer's disease patients revealed dysregulated proteins in the disease and novel proteins associated with amyloid-β pathology
    Montero-Calle, Ana
    Coronel, Raquel
    Garranzo-Asensio, Maria
    Solis-Fernandez, Guillermo
    Rabano, Alberto
    de los Rios, Vivian
    Fernandez-Acenero, Maria Jesus
    Mendes, Marta L.
    Martinez-Useros, Javier
    Megias, Diego
    Moreno-Casbas, Maria Teresa
    Pelaez-Garcia, Alberto
    Liste, Isabel
    Barderas, Rodrigo
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2023, 80 (06)
  • [27] An immunohistochemical study of the serotonin 1A receptor in the hippocampus of subjects with Alzheimer's disease
    Mizukami, Katsuyoshi
    Ishikawa, Masanori
    Akatsu, Hiroyasu
    Abrahamson, Eric E.
    Ikonomovic, Milos D.
    Asada, Takashi
    NEUROPATHOLOGY, 2011, 31 (05) : 503 - 509
  • [28] Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer’s disease-related proteins
    Srikant Rangaraju
    Eric B. Dammer
    Syed Ali Raza
    Tianwen Gao
    Hailian Xiao
    Ranjita Betarbet
    Duc M. Duong
    James A. Webster
    Chadwick M. Hales
    James J. Lah
    Allan I. Levey
    Nicholas T. Seyfried
    Molecular Neurodegeneration, 13
  • [29] Single-Base Resolution Mapping of 5-Hydroxymethylcytosine Modifications in Hippocampus of Alzheimer's Disease Subjects
    Ellison, Elizabeth M.
    Bradley-Whitman, Melissa A.
    Lovell, Mark A.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2017, 63 (02) : 185 - 197
  • [30] Quantitative proteomics identifies altered O-GlcNAcylation of structural, synaptic and memory-associated proteins in Alzheimer's disease
    Wang, Sheng
    Yang, Feng
    Petyuk, Vladislav A.
    Shukla, Anil K.
    Monroe, Matthew E.
    Gritsenko, Marina A.
    Rodland, Karin D.
    Smith, Richard D.
    Qian, Wei-Jun
    Gong, Cheng-Xin
    Liu, Tao
    JOURNAL OF PATHOLOGY, 2017, 243 (01) : 78 - 88